--- title: "VCANBIO: VUM02 injection for the treatment of active moderate to severe ulcerative colitis clinical trial approved" type: "News" locale: "en" url: "https://longbridge.com/en/news/222533692.md" description: "According to the Zhitong Finance APP, VCANBIO announced that its wholly-owned subsidiary Wuhan Guanggu VCANBIO Pharmaceutical Co., Ltd. received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical Products Administration on December 16 for the use of VUM02 injection in the treatment of active moderate to severe ulcerative colitis" datetime: "2024-12-17T09:17:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/222533692.md) - [en](https://longbridge.com/en/news/222533692.md) - [zh-HK](https://longbridge.com/zh-HK/news/222533692.md) generator: "portal-rs" --- # VCANBIO: VUM02 injection for the treatment of active moderate to severe ulcerative colitis clinical trial approved According to the Zhitong Finance APP, VCANBIO (600645.SH) announced that its wholly-owned subsidiary, Wuhan Guanggu VCANBIO Pharmaceutical Co., Ltd., received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration on December 16th for the use of VUM02 injection in the treatment of active moderate to severe ulcerative colitis ### Related Stocks - [600645.CN](https://longbridge.com/en/quote/600645.CN.md) ## Related News & Research - [ZAWYA: Nigeria: How public funds were moved from LG account into crypto wallets ?](https://longbridge.com/en/news/298209591.md) - [Action On Clean Air And Climate Change Can Net $15 For Every Dollar Spent: Report](https://longbridge.com/en/news/298212133.md) - [Elizabeth Warren Says Republicans Will 'Outspend' and Trump Will 'Throw Dirt,' but Democrats Have What GOP Doesn't: 'That's How We Win'](https://longbridge.com/en/news/298176127.md) - [Ugandan kingdom gripped by succession battle after monarch's death](https://longbridge.com/en/news/298567985.md) - [Marguerite-backed SWAN agrees to buy Slovak fixed-line operator Slovanet](https://longbridge.com/en/news/298615963.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**